North America Nuclear Medicine Radiopharmaceuticals Market is set to cross 1.5 billion by 2022
According to North America Nuclear Medicine Radiopharmaceuticals Market report, published by Market Data Forecast, the North America market is projected to reach USD 1.53 billion by 2022, at a CAGR of 11.2% from 2017 to 2022.
(EMAILWIRE.COM, November 30, 2017 ) According to North America Nuclear Medicine Radiopharmaceuticals Market report, published by Market Data Forecast, the North America market is projected to reach USD 1.53 billion by 2022, at a CAGR of 11.2% from 2017 to 2022.
Nuclear medicine comes under the area of Molecular imaging, which covers the usage of the traces left by radioactive substance (radiopharmaceuticals) for detection and treatment of disorders.
Get a comprehensive overview of the North America Nuclear Medicine Radiopharmaceuticals Market: http://www.marketdataforecast.com/market-reports/north-america-nuclear-medicine-radiopharmaceuticals-market-129/
North America Nuclear Medicine Radiopharmaceuticals Market: Drivers & Restraints
Gradually increasing prevalence of cancer and heart disorders, technically advancing innovation, public becoming aware about healthcare are driving factors here. The development of integrated X ray tomography (CT) is becoming increasingly popular day by day. But, strict laws and framework deter the steep growth curve. Also, alternative options hamper the market growth.
Get accurate market forecast and analysis on the North America Nuclear Medicine Radiopharmaceuticals Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/north-america-nuclear-medicine-radiopharmaceuticals-market-129/request-sample
North America Nuclear Medicine Radiopharmaceuticals Market: Segmentation
By Diagnostic radioisotopes
SPECT (Technetium-99m, Thallium-201 Gallium-67, Iodine)
PET (Fluorine-18, Rubidium-82)
By Therapeutic radioisotopes
Beta emitters (Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177)
Alpha Emitters (Radium-223)
Brachytherapy (Cesium-131, Iodine-125, Palladium-103, Iridium-192)
By Application
cardiology
lymphoma
thyroid
neurology oncology
others
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/north-america-nuclear-medicine-radiopharmaceuticals-market-129/customize-report
North America Nuclear Medicine Radiopharmaceuticals Market: Overview
Radiopharmaceuticals market is dominated by diagnostic radioisotopes Detection of diseases like coronary artery disorder, bone metastasis, and Alzheimers disorder are the biggest scopes for the future PET radioisotopes market.
In North America Nuclear Medicine Radiopharmaceuticals Market, United States has the largest consumer base for radioisotopes and Canada is a huge manufacturer of Tc-99m.
North America Nuclear Medicine Radiopharmaceuticals Market: Key Players
Players dominating this market are GE Healthcare, Lantheus Medical Imaging, Inc., Hologic Inc., Naviscan Inc., Medix Inc., Bracco Imaging S.p.A, Bayer Healthcare, Segami Corporation,Positron Corporation, and IBA Molecular Imaging.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Nuclear medicine comes under the area of Molecular imaging, which covers the usage of the traces left by radioactive substance (radiopharmaceuticals) for detection and treatment of disorders.
Get a comprehensive overview of the North America Nuclear Medicine Radiopharmaceuticals Market: http://www.marketdataforecast.com/market-reports/north-america-nuclear-medicine-radiopharmaceuticals-market-129/
North America Nuclear Medicine Radiopharmaceuticals Market: Drivers & Restraints
Gradually increasing prevalence of cancer and heart disorders, technically advancing innovation, public becoming aware about healthcare are driving factors here. The development of integrated X ray tomography (CT) is becoming increasingly popular day by day. But, strict laws and framework deter the steep growth curve. Also, alternative options hamper the market growth.
Get accurate market forecast and analysis on the North America Nuclear Medicine Radiopharmaceuticals Market. Request a sample to stay up-to-date on the main trends affecting this market: http://www.marketdataforecast.com/market-reports/north-america-nuclear-medicine-radiopharmaceuticals-market-129/request-sample
North America Nuclear Medicine Radiopharmaceuticals Market: Segmentation
By Diagnostic radioisotopes
SPECT (Technetium-99m, Thallium-201 Gallium-67, Iodine)
PET (Fluorine-18, Rubidium-82)
By Therapeutic radioisotopes
Beta emitters (Iodine-131, Yttrium-90, Samarium-153, Rhenium-186, Lutetium-177)
Alpha Emitters (Radium-223)
Brachytherapy (Cesium-131, Iodine-125, Palladium-103, Iridium-192)
By Application
cardiology
lymphoma
thyroid
neurology oncology
others
From simple data collation through secondary and primary research to ad-hoc research requests relating to specific information, we provide our services via customization. Get customization at http://www.marketdataforecast.com/market-reports/north-america-nuclear-medicine-radiopharmaceuticals-market-129/customize-report
North America Nuclear Medicine Radiopharmaceuticals Market: Overview
Radiopharmaceuticals market is dominated by diagnostic radioisotopes Detection of diseases like coronary artery disorder, bone metastasis, and Alzheimers disorder are the biggest scopes for the future PET radioisotopes market.
In North America Nuclear Medicine Radiopharmaceuticals Market, United States has the largest consumer base for radioisotopes and Canada is a huge manufacturer of Tc-99m.
North America Nuclear Medicine Radiopharmaceuticals Market: Key Players
Players dominating this market are GE Healthcare, Lantheus Medical Imaging, Inc., Hologic Inc., Naviscan Inc., Medix Inc., Bracco Imaging S.p.A, Bayer Healthcare, Segami Corporation,Positron Corporation, and IBA Molecular Imaging.
About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more information, kindly visit, www.marketdataforecast.com.
Visit Market Data Forecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Contact Information:
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Market Data Forecast.
Abhishek
Tel: +1-888- 702-9626
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results